60 Degrees Pharmaceuticals, Inc.

8-K Regulation FD disclosure Jul 20, 2026 8-K Other events Jul 9, 2026 8-K Other events Jun 3, 2026 8-K Director or officer change May 18, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Other events Mar 20, 2026 8-K Other events Mar 13, 2026 8-K Other events Mar 12, 2026 8-K Other events Feb 12, 2026 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Jan 23, 2026 8-K Amended charter or bylaws; Other events Jan 21, 2026 8-K Regulation FD disclosure Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Shareholder vote results Oct 10, 2025 8-K Regulation FD disclosure Sep 9, 2025 8-K Entered a material agreement; Terminated a material agreement Sep 5, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Entered a material agreement; Other events Jul 18, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Other events Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Feb 6, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 30, 2025 8-K Other events Jan 28, 2025 8-K Other events Jan 8, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Shareholder vote results Nov 6, 2024 8-K Other events Oct 8, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 6, 2024 8-K Other events Aug 28, 2024 8-K Other events Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Amended charter or bylaws; Other events Aug 12, 2024 8-K Other events Jul 26, 2024 8-K Shareholder vote results Jul 16, 2024 8-K Other events Jul 9, 2024 8-K Other events Jun 27, 2024 8-K Other events Jun 12, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024